ArticleUpdates in surgery2026
Omentopexy after laparoscopic sleeve gastrectomy in children and adolescents: is it effective in reducing post-operative complications?
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laparoscopic sleeve gastrectomy (LSG) is one of the most commonly performed restrictive bariatric procedures. Postoperative gastrointestinal complications are distressing in patients who have undergone this procedure. Most of these complications can be prevented by omentopexy as a modification on laparoscopic sleeve gastrectomy. The purpose of this study was to evaluate the effectiveness of omentopexy during laparoscopic sleeve gastrectomy in reducing postoperative complications. This prospective comparative study, conducted between January 2015 and October 2024 at Al-Azhar University Hospitals, encompassed 48 pediatric patients diagnosed with obesity. The patients were randomly allocated into two groups: group 1 comprised 24 patients treated with LSG with omentopexy and group 2 comprised 24 patients treated with LSG without omentopexy. Preoperative data and postoperative outcomes were collected for all patients in each group. 48 morbidly obese patients, divided into two groups of 24 each, were included in this study. Both groups were comparable in baseline characteristics including age, sex distribution, BMI, preoperative GERD-Q scores, and comorbidities. Operative times were significantly longer in the omentopexy group (64.23 ± 8.12 min) compared to the non-omentopexy group (54.15 ± 5.02 min, P = 0.044). The omentopexy group had significantly lower rates of nausea (8.3% vs. 20.8%), vomiting (8.3% vs. 33.3%), and regurgitation (8.3% vs. 16.6%). One case of staple line leak occurred in the non-omentopexy group, a difference that was not statistically significant. Hospital stay was significantly shorter in the omentopexy group (1.78 ± 0.858 days) compared to the non-omentopexy group (4.47 ± 1.25 days, P = 0.011). Both groups achieved comparable weight loss (BMI: 27.35 ± 4.57 vs. 28.85 ± 5.68) and postoperative GERD-Q scores (6.73 ± 1.86 vs. 6.85 ± 2.01), indicating similar efficacy in the treatment of obesity. Omentopexy following laparoscopic sleeve gastrectomy is associated with a significant reduction in early post-operative nausea and vomiting and a shorter hospital stay. While there were no staple line leaks in the omentopexy group, this study was not powered to definitively conclude a reduction in this complication. Also, the extent to which this technique alleviates gastroesophageal reflux disease remains uncertain.
Indexed as
Identifiers
41686405What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.